First-line management of metastatic urothelial cancer: Current and future perspectives after the EV-302 and CcheckMate-901 studies
Keywords:
Molecular characterization
Paradigm shift
Sequence of treatments
Personalized treatment
Immune therapy
Citation:
Fenor-de-la-Maza, M.D. (Maria Dolores); Villacampa, G. (Guillermo); Miñana, B. (Bernardino); et al. "First-line management of metastatic urothelial cancer: Current and future perspectives after the EV-302 and CcheckMate-901 studies". Clinical Genitourinary Cancer. S1558-7673 (23), 2023, 00267-7
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.